Jacques Barbet
7Patents
5h-index
14Co-inventors
60Inventor score
Filing activity: Sep 10, 1987 → Dec 23, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5256395A | Affinity enhancement immunological reagents for in vivo detection and killing of specific target cells | Human Necessities | 90 | Expired |
| US5274076A | Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents | Human Necessities | 35 | Expired |
| US9334330B2 | Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers | Chemistry; Metallurgy | 14 | Active |
| US5449601A | Process for the identification or determination of proteins and its applications | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8951524B2 | Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancers | Chemistry; Metallurgy | 8 | Active |
| US6326401A | Formulation for the oromucosal, in particular pernasal, route | Human Necessities | 2 | Expired |
| US9809624B2 | Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.